首页> 外文OA文献 >Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

【2h】

Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

机译：作者对Srinivas的回复：“选择性JAK1抑制剂Filgotinib的药代动力学和药代动力学/药效学建模（GLPG0634），支持IIB期剂量选择”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Florence Namour;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection" [J] . Namour Florence Clinical pharmacokinetics . 2015,第12期

机译：作者对Srinivas的答复：“选择性JAK1抑制剂Filgotinib的药代动力学和药代动力学/药效学建模（GLPG0634），支持IIB期剂量选择”
2. Comment on: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modelling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection" [J] . Srinivas Nuggehally R. Clinical pharmacokinetics . 2015,第12期

机译：评论：“选择性JAK1抑制剂Filgotinib（GLPG0634）的药代动力学和药代动力学/药效动力学模型，支持IIB期剂量选择”
3. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection [J] . Namour Florence, Diderichsen Paul Matthias, Cox Eugene, Clinical pharmacokinetics . 2015,第8期

机译：Filgotinib（GLPG0634）（一种选择性的JAK1抑制剂）的药代动力学和药代动力学/药效学建模，支持IIB期剂量选择
4. Optimal drug dosing control for intensive care unit sedation using a hybrid deterministic-stochastic pharmacokinetic and pharmacodynamic model [C] . Gholami B., Haddad W.M., Bailey J.M., 49th IEEE Conference on Decision and Control . 2010

机译：使用混合确定性-随机药代动力学和药效学模型的重症监护病房镇静的最佳药物剂量控制
5. Pharmacokinetics and pharmacodynamics of the selective serotonin reuptake inhibitors, fluoxetine and paroxetine, during pregnancy and the nursing period. [D] . Kim, John. 2001

机译：选择性5-羟色胺再摄取抑制剂氟西汀和帕罗西汀在怀孕和哺乳期的药代动力学和药效学。
6. Author’s Reply to Srinivas: Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634) a Selective JAK1 Inhibitor in Support of Phase IIB Dose Selection [O] . Florence Namour -1

机译：作者对Srinivas的回复：选择性JAK1抑制剂Filgotinib（GLPG0634）的药代动力学和药代动力学/药效学建模支持IIB期剂量选择
7. Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection [O] . Florence Namour, Paul Matthias Diderichsen, Eugène Cox, 2015

机译：Filgotinib（GLPG0634）（一种选择性的JAK1抑制剂）的药代动力学和药代动力学/药效学建模，支持IIB期剂量选择

Author’s Reply to Srinivas: “Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection”

著录项

引文网络

相似文献

相关主题

期刊订阅